🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
38.66
-0.30 (-0.78%)
At close: Nov 20, 2026, 4:00 PM EST
38.64
-0.02 (-0.04%)
After-hours: Nov 20, 2026, 7:53 PM EST

Roivant Sciences Revenue

Roivant Sciences had revenue of $35.12M in the quarter ending September 30, 2026, with 2,135.58% growth. This brings the company's total for the last twelve months to $41.08M, up 102.09% year-over-year. In the fiscal year ending March 31, 2026, Roivant Sciences had annual revenue of $8.26M, down -71.57%. That makes Roivant Sciences the 29,398th largest company in the world by revenue and 3,899th in the United States.

Revenue (ttm)
$41.08M
Revenue Growth
+102.09%
P/S Ratio
681.76
Revenue / Employee
$56,979
Employees
721
Market Cap
28.01B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 20268.26M-20.79M-71.57%
Mar 31, 202529.05M-3.66M-11.19%
Mar 31, 202432.71M-28.57M-46.62%
Mar 31, 202361.28M5.99M10.84%
Mar 31, 202255.29M31.49M132.34%
Mar 31, 202123.80M-43.89M-64.85%
Mar 31, 202067.69M65.37M2,812.61%
Mar 31, 20192.32M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
BeOne Medicines AG6.45B
Incyte6.01B
Alnylam Pharmaceuticals5.01B
Genmab4.30B
BioNTech SE2.75B
Royalty Pharma2.62B
Exelixis2.50B
Insmed1.52B
Revenue Rankings